NUTM1
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
NUT midline carcinoma family member 1 | MIM:608963 | Ensembl:ENSG00000184507 | HGNC:HGNC:29919 | PA162378206 | 15q14 |
GO terms in NUTM1
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IPI | GO:0005515 | protein binding |
CC | IEA | GO:0005634 | nucleus |
CC | IEA | GO:0005737 | cytoplasm |
Gene expression in normal tissue: NUTM1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in NUTM1
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD494 | Neopeltolide | 3 |
iGMDRD427 | ABT737 | 3 |
iGMDRD670 | ML 210 | 6 |
iGMDRD152 | 179324-69-7 | 3 |
iGMDRD61 | Kinetin riboside | 6 |
iGMDRD446 | LY 2183240 | 3 |
iGMDRD513 | BML-259 | 1 |
iGMDRD474 | Avrainvillamide | 3 |
iGMDRD138 | PX 12 | 1 |
iGMDRD441 | TW 37 | 2 |
iGMDRD187 | BRD9876 | 1 |
iGMDRD870 | BRD63610 | 6 |
iGMDRD562 | Navitoclax | 3 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD100 | Zebularine | 2 |
iGMDRD451 | Serdemetan | 2 |
iGMDRD64 | Parbendazole | 3 |
iGMDRD512 | nutlin 3 | 4 |
iGMDRD330 | BRD4132 | 1 |
iGMDRD307 | Manumycin A | 6 |
iGMDRD523 | Cyanoquinoline, 11 | 3 |
iGMDRD424 | Tamatinib | 3 |
iGMDRD314 | Tanespimycin | 3 |
iGMDRD351 | GW843682X | 3 |
iGMDRD341 | Triacsin c | 6 |
iGMDRD945 | ML214 | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 1 |
iGMDRD251 | ML162 | 3 |
iGMDRD137 | Indisulam | 3 |
iGMDRD202 | Curcumin | 2 |
iGMDRD121 | GMX1778 | 7 |
iGMDRD481 | Dactolisib | 2 |
iGMDRD267 | Oligomycin A | 3 |
iGMDRD105 | Triptolide | 1 |
iGMDRD289 | Parthenolide | 8 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD286 | Nsc 632839 | 2 |
iGMDRD871 | BRD6368 | 1 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD322 | FK 866 | 5 |
iGMDRD505 | Pevonedistat | 3 |
iGMDRD191 | FMK | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in NUTM1